Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isracann Biosciences Inc ISCNF

Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.


GREY:ISCNF - Post by User

Bullboard Posts
Post by Bobowskion Dec 16, 2019 4:18pm
270 Views
Post# 30460730

Isracann

IsracannI would like to address a couple of concerns I saw in this post chain. First, I doubt the short sellers are insiders as the short sellers have been attacking the cannabis sector for about the past nine months so this is nothing new. Second, this is not a pump and dump (at least not in the traditional sense of the term) as there is more to be gained down the road (more on this below).The insiders are not going to be selling for 35 or 51 cents or even a buck when there is much more to be gained later on. Of course Isracann have nothing now as they have not even started construction yet, but they will be in production by the end of 2020. The Israel cannabis sector is where Canada was about two years ago. That being said, there is likely to be pricing pressure when the 51 cent financing hold period ends on January 31, 2020, as more short sellers show up (as they always do) when a hold period is coming to an end. So what is the big play that will produce these larger gains in 12 to 18 months? It is a buy out by a large Licensed Producer (probably a Canadian LP like Canopy or Aurora). They would not only love to get their hands on a low cost (40 cents a gram) producer in the middle of an under served market like Israel, but also because of the close proximity to Europe (the largest cannabis market in the world). Israel is only the third country in the world that is allowed to export cannabis to Europe (the other two being Canada and the Netherlands). So how much could the windfall be? Well...at a production capacity of 23,500 kilograms  (23,500,000 grams) at $5 per gram (wholesale) is about $115 million, times (a buy out price of 4 times revenue) divided by 155 million shares outstanding (fully diluted) is about $3 a share, not to mention Isracann (or the new owner) can expand their facility to 580,000 square feet which would be an added kicker to the buy out price. This could  be a 10 bagger. I am not an insider nor do I work for Isracann. I am just an ordinary investor like most of you.  
Bullboard Posts